Technical Article
Bilayer Gastroretentive Modified-Release Tablets: A Quality-by-Design Approach to Achieving Precise Drug Release and Prolonged Gastric Retention
01 Apr 2026
Crystal Bio's CSO, Billy Wu, Ph.D. will be in San Francisco with Crystal Pharmatech's BD Director, Chris Heard, for the American Association of Pharmaceutical Scientists (AAPS) | @aapscomms National Biotechnology Conference.
Discuss US-based biologics analytical services including:
· Antibody-based biologics
· Novel combinations of ADC and cell/gene therapy
· Ligand binding assays with LC-MS for serum stability and PK/PD-related analysis
Subscribe to be the first to get the updates!